Haas, Tobias Longin
 Distribuzione geografica
Continente #
NA - Nord America 1.177
EU - Europa 795
AS - Asia 339
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.315
Nazione #
US - Stati Uniti d'America 1.175
SE - Svezia 314
CN - Cina 251
PL - Polonia 129
IT - Italia 124
IE - Irlanda 68
SG - Singapore 42
UA - Ucraina 27
DE - Germania 24
FR - Francia 22
GB - Regno Unito 20
RU - Federazione Russa 20
ES - Italia 17
TR - Turchia 17
BE - Belgio 12
IN - India 12
AT - Austria 6
VN - Vietnam 6
NL - Olanda 5
FI - Finlandia 4
HK - Hong Kong 4
BR - Brasile 2
CH - Svizzera 2
IR - Iran 2
JP - Giappone 2
CA - Canada 1
CL - Cile 1
EU - Europa 1
HR - Croazia 1
IQ - Iraq 1
LK - Sri Lanka 1
PK - Pakistan 1
PR - Porto Rico 1
Totale 2.315
Città #
Chandler 175
Ashburn 152
Warsaw 129
Fairfield 99
Dublin 68
Nanjing 61
Dearborn 56
Wilmington 52
Houston 45
Ann Arbor 41
Redmond 39
Princeton 38
Woodbridge 38
Cambridge 35
Jacksonville 34
Seattle 33
Cattolica 32
San Mateo 30
Rome 24
Singapore 24
Nanchang 21
Kunming 19
Los Angeles 18
Beijing 17
Shenyang 17
Hebei 15
Izmir 15
Redwood City 15
Boston 14
Brussels 12
Moscow 12
New York 12
Donostia / San Sebastian 11
Shanghai 11
Chicago 10
Changsha 9
Tianjin 9
Washington 9
Guangzhou 8
Hefei 8
Hangzhou 7
Mountain View 7
Norwalk 7
Dong Ket 6
San Diego 6
Vienna 6
Bremen 5
London 5
Marseille 5
Milan 5
Andover 4
Changchun 4
Falls Church 4
Gurgaon 4
Hong Kong 4
Sangüesa 4
Santa Clara 4
Augusta 3
Boardman 3
Genoa 3
Jiaxing 3
Zhengzhou 3
Catanzaro 2
Changshahsien 2
Chiswick 2
Crick 2
Edinburgh 2
Fort Worth 2
Genova 2
Groningen 2
Gualdo Cattaneo 2
Helsinki 2
Kocaeli 2
Lanzhou 2
Madrid 2
Pace del Mela 2
Phoenix 2
Salò 2
San Jose 2
Turin 2
Verona 2
Wuhan 2
Zurich 2
Acton 1
Amsterdam 1
Baghdad 1
Benevento 1
Bergamo 1
Brindisi 1
Chaoyang 1
Chengdu 1
Clifton 1
Colombo 1
Concepción 1
Curitiba 1
Faisalabad 1
Falkenstein 1
Florence 1
Frankfurt am Main 1
Frederick 1
Totale 1.628
Nome #
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells 249
Two-Step Co-Immunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein-Complexes. 238
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer 136
Inhibitor of integrin for the treatment or prevention of tumours 127
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 103
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis 95
Integrin a7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 93
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 82
Two-Step Coimmunoprecipitation (TIP) enables efficient and highly selective isolation of native protein complexes 78
Two-Step Co-Immunoprecipitation (TIP) 78
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L 63
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 62
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture 58
Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complex 54
Lung cancer stem cells: Tools and targets to fight lung cancer 51
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis 49
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 48
Linear ubiquitination prevents inflammation and regulates immune signalling 45
The linear ubiquitin chain assembly complex (LUBAC) forms part of the TNF-R1 signalling complex and is required for effective TNF-induced gene induction and prevents TNF-induced apoptosis 44
CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling 42
Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts 41
Polymeric substrates with tunable elasticity and nanoscopically controlled biomolecule presentation 35
Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects 34
Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis 33
Biochemical analysis of the native TRAIL death-inducing signaling complex 32
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture 31
Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction 30
Regulation of Enterocyte Apoptosis by Acyl-CoA Synthetase 5 Splicing 29
Small molecule XIAP inhibitors enhance TRAIL-Lnduced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma 29
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway 29
Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo 27
TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window 26
Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis 26
Biochemical analysis of the native TRAIL death-inducing signaling complex 26
NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2 25
Enhanced caspase-8 recruitment to and activation at the disc is critical for sensitisation of human hepatocellular carcinoma cells to trail-induced apoptosis by chemotherapeutic drugs 25
Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL 22
Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs 22
Micro-nanostructured protein arrays: a tool for geometrically controlled ligand presentation 22
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors 21
The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8) 13
Totale 2.373
Categoria #
all - tutte 11.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.102


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020525 80 36 48 89 44 58 58 18 24 11 45 14
2020/2021186 12 13 24 8 36 11 18 5 14 15 20 10
2021/2022295 22 15 7 14 29 33 5 54 14 24 49 29
2022/2023645 124 102 65 58 59 67 25 44 61 11 18 11
2023/2024389 10 98 16 44 13 49 18 11 3 33 49 45
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 2.373